Century Pharmaceuticals Limited
Sayajiganj, Vadodara, Gujarat
SEND SMS
SEND EMAIL
Established in the year 1989, we, 'Century Pharmaceuticals Limited', are an ISO 9001:2008 certified and established manufacturer and supplier of quality Active Pharmaceutical Ingredients, Animal Health Medicines, Bimatoprost Drugs. These products offered by us are processed using quality ingredients sourced from the trustworthy vendors of the market. Our products are highly utilized and accredited throughout the country for their superior quality, effective performance, and environment friendly, safe to use, reliable and result oriented qualities. The offered range is processed under Quality certified manufacturing unit.
Our skilled and experienced professionals have in-depth knowledge in formulating the feed supplements as per the international quality standards. Our products are offered at most reasonable prices and are in compliance with the Quality Standards. Moreover, we have a developed a well-maintained and sophisticated warehouse that is equipped with utmost hygienic conditions required for the storage of our products.
Under the dynamic leadership of our mentor "Mr. Balkrishna Shetty", we have been able to climb up the ladders of growth and success in this highly competitive market. Owing to our timely delivery and good transport facility, we are able to provide these products to our clients in the committed time frame.
|
We have all the necessary expertise and knowledge to undertake contracts for analytical method development and stability studies. The expert knowledge and extensive practical experience of our professionals helps us complete these contracts to the full contentment of the clients. Stability studies are an indispensable part of drug development process, which involves examination and evaluation of APIs and other biotechnology products under varying temperature conditions. These studies help in supporting the quality, shelf-life, safety and efficacy claims of the drugs under investigation.
We have affirmed the role of biotechnology in shaping the future of pharmaceutical industry by enhancing the specificity and effectiveness of drugs, improving lifestyle quality and working on unmet needs of the industry. We are engaged in undertaking significant biotechnology research activities in the area of targeted human therapeutic proteins. Our current research work focuses on creating a novel drug, which while curing asthma and allergy patients can also work on mastocytosis and basophilic leukemia. This highly potent drug is still in early stages of development. Further, we also commence supplies of research grade biotechnology products at highly affordable rates with assured confidentiality. Our organization is also inclined towards undertaking research and analytical development of recombinant proteins for biotechnology companies on contractual basis.
Our consistent success shares its credit with the hard work and brilliance of our team of professionals. Selected after a rigorous screening process, these individuals are crème la de crème of the available human resources. They are not only proficient in their own trade, but also have all round capabilities, which makes them capable of assaying multiple roles as and when need arises. Our team of chemists and researchers, work through a gruelling schedule to produce medical wonders for the betterment of mankind. They have a knack of sensing the future needs of health industry and work accordingly. These 100 enlightened individuals help us rewrite history by developing novel and futuristic solutions time and again.
Our team mainly comprises:
Century Pharmaceuticals Ltd welcomes the future with open arms. Looking into the past, we have built a strong present to face a challenging future. The company has a vision to enter into new markets, launch innovative products, and build a brand that will carry itself across the world.
We welcome Venture Capitalists to invest with us in the development of a novel recombinant protein for the treatment and cure of Asthma and Allergies for the first time in the world. Other indications are Mastocytosis and Basophilic Leukaemia. Once we are able to successfully develop this product, we will provide a new direction to targeted therapeutics for other chronic diseases and find cures for them !
